WHO ICTRP trial
The effect of myoinositol supplementation on the prevention of gestational…
IRCT20120826010664N4 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20120826010664N4 |
|---|---|
| Public title | The effect of myoinositol supplementation on the prevention of gestational diabetes mellitus |
| Scientific title | The effect of myoinositol supplementation on the prevention of gestational diabetes mellitus in high-risk women |
| Primary sponsor | Tehran University of Medical Sciences |
| Secondary sponsors | Health Parsian |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of);Iran (Islamic Republic of) |
| Conditions | Gestational diabetes mellitus (GDM). Gestational diabetes mellitus;O24.4 |
| Interventions | Intervention 1: Intervention group: 2 gr of myoinositol plus 200 micro gr folic acid twice a day orally, from 14th week of gestation until 28th week. Intervention 2: Control group: 200 micro gr folic acid twice a day. |
| Registration date | May 8, 2019 |
| Target size | 276 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: